TruTrace Technologies Inc (CVE:TTT) (OTCMKTS:BKKSF) said Thursday that Canadian medical and recreational cannabis grower Zenabis Global Inc (OTCMKTS:ZBISF) will use its StrainSecure platform to collect, register, track and publish verified testing data for its cannabis strains.
The Vancouver-based firm combines the power of big data with the security of blockchain to provide strain identification, registration and verification to cannabis companies.
The firm's proprietary StrainSecure platform establishes integrity and quality assurance measures. The blockchain-based platform is designed to guarantee product quality and genetics throughout the cannabis supply chain from genome to patient.
The company said that its StrainSecure platform is intended to enable Zenabis to "validate its cannabis strains" and provide its customers with transparency about the authenticity, quality and origin of its products.
In addition, Zenabis is joining the medical cannabis verification pilot project being run by TruTrace and Canadian retail pharmacy chain Shoppers Drug Mart launched last week at the World Cannabis Congress in Saint John in Canada. The project is aimed at improving industry accountability and patient outcomes.
"This initiative continues to gain momentum with the signing of a forward-thinking cannabis cultivator like Zenabis who recognizes the value of providing verified product data to their patients and customers," said TruTrace Technologies CEO Robert Galarza. "The recent launch of this traceability pilot project with Canada's leading pharmacy brand demonstrates the importance of standardization and traceability in designing and evaluating treatment programs for patients."
Phase 1 of the pilot project is expected to be completed by July 31, with full production and implementation targeted for late-November.
TruTrace's StrainSecure platform
TruTrace's StrainSecure platform will allow growers and breeders to identify and secure rights to their IP while streamlining admin and reducing the costs for genetic and mandatory quality-control testing for legal cannabis. The fact is that consumers and regulators both want to know whether a cannabis product sold at a dispensary is safe and meets quality control standards.
"We're extremely excited to be part of the pioneer group of licensed producers partnered with TruTrace Technologies and Shoppers Drug Mart, who are committed to increasing transparency, traceability, and standardization in the cannabis industry,” said David Lluncor, chief revenue officer at Zenabis. “We're happy to be able to play a role in offering Canadian medical patients and adult-use consumers assurances that they are being supplied safe, high quality, cannabis and hemp CBD products."
Under the StrainSecure program, the TruTrace team collects plant testing data and performs genomic verification in plant batches which are then registered in a blockchain-enabled database for intellectual property protection and strain validation. Information gathered from the plants, including their molecular and chemical makeup, can be tracked through the program.
Since the start of 2019, TruTrace Technologies has signed on several licensed growers to its StrainSecure platform.
Contact Uttara Choudhury at [email protected]